Joshua Allen
Directeur Technique/Scientifique/R&D chez CHIMERIX, INC.
Postes actifs de Joshua Allen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CHIMERIX, INC. | Directeur Technique/Scientifique/R&D | 01/01/2021 | - |
Historique de carrière de Joshua Allen
Anciens postes connus de Joshua Allen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Oncoceutics, Inc.
 Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | Directeur Technique/Scientifique/R&D | 01/09/2014 | 01/01/2021 |
Formation de Joshua Allen
| University of Pennsylvania | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Oncoceutics, Inc.
Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | Health Technology |
- Bourse
- Insiders
- Joshua Allen
- Expérience
